{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:10:14Z","timestamp":1785769814655,"version":"3.56.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:p>\n                    The coronavirus disease (COVID-19) pandemic has been associated with an increased burden of secondary infections, including fungal infections of the lungs, especially in critically ill patients. However, it is unclear whether this excess risk persisted in the post-pandemic period after infection-control practices and clinical pathways were optimized. This single-center retrospective observational study included 1441 PCR positive COVID-19 patients hospitalized during the COVID-19 pandemic and after the pandemic. Microbiological investigations, fungal cultures, serum galactomannan antigen tests, and\n                    <jats:italic toggle=\"yes\">Pneumocystis jirovecii<\/jats:italic>\n                    PCR tests were performed. The rates of positive test results for fungal infections were calculated as percentages and statistically compared between the 2 periods. Overall, 99 of 1441 patients (6.9%) had at least 1 positive fungal test. The study findings showed that the positive test results for fungal species declined after the pandemic, from 9.15% to 5.13% for all species, 17.36% to 9.29% for\n                    <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                    species, and 2.22% to 1.00% for\n                    <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                    species. The decrease in the positive test result rates for all fungal and\n                    <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                    species was statistically significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002, respectively). An increased prevalence of pulmonary fungal infections was observed in patients hospitalized during the COVID-19 pandemic. The lower fungal positivity observed in the post-pandemic period may reflect changes in the patient case-mix, diagnostic intensity, and evolving clinical and infection-control practices; however, causal inferences cannot be made from this observational analysis. These findings may inform preparedness, infection-control, and stewardship strategies for preventing and managing pulmonary fungal co-infections during future respiratory virus outbreaks.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048245","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:01:22Z","timestamp":1775840482000},"page":"e48245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Fungal infections of the lung during and after the COVID-19 pandemic: Retrospective observational comparison"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1687-6483","authenticated-orcid":false,"given":"Orhan","family":"Dalkili\u00e7","sequence":"first","affiliation":[{"name":"Department of Pulmonology, Hisar Intercontinental Hospital, \u0130stanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-6508","authenticated-orcid":false,"given":"\u015eeyma","family":"Ba\u015flilar","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital, \u0130stanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-4752","authenticated-orcid":false,"given":"Ramazan","family":"G\u00f6z\u00fck\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Microbiology, Hisar Intercontinental Hospital, \u0130stanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-599X","authenticated-orcid":false,"given":"Bekir Sami","family":"Uyanik","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Hisar Intercontinental Hospital, \u0130stanbul, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit.","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2020.03.065","article-title":"Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis.","volume":"81","author":"Bassetti","year":"2020","journal-title":"J Infect"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jointm.2024.01.005","article-title":"Fungal infections in immune compromised critically ill patients.","volume":"4","author":"Garnacho-Montero","year":"2024","journal-title":"J. Intensive Med"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections.","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000-2013.","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing.","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10238-021-00751-7","article-title":"COVID-19-associated opportunistic infections: a snapshot on the current reports.","volume":"22","author":"Abdoli","year":"2022","journal-title":"Clin Exp Med"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/jof8020161","article-title":"Association of COVID-19-associated pulmonary aspergillosis with cytomegalovirus replication: a case-control study.","volume":"8","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R9-20260410","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU.","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.riam.2020.07.001","article-title":"Fungal co-infection in COVID-19 patients: should we be concerned?","volume":"37","author":"Pem\u00e1n","year":"2020","journal-title":"Rev Iberoam Micol"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"104806","DOI":"10.1016\/j.micinf.2021.104806","article-title":"Bacterial and fungal co-infections among COVID-19 patients in intensive care unit.","volume":"23","author":"Yang","year":"2021","journal-title":"Microbes Infect"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of respiratory viral and fungal coinfections.","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.12669\/pjms.39.5.7301","article-title":"The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients.","volume":"39","author":"Gozukucuk","year":"2023","journal-title":"Pak J Med Sci"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmii.2020.08.016","article-title":"SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.","volume":"54","author":"Parrill","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bmj.p1378","article-title":"Fungal infections are especially dangerous for covid-19 patients, CDC study warns.","volume":"381","author":"Tanne","year":"2023","journal-title":"BMJ"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"105039","DOI":"10.1016\/j.micinf.2022.105039","article-title":"COVID-19 and fungal infections: a double debacle.","volume":"24","author":"Mina","year":"2022","journal-title":"Microbes Infect"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/myc.13332","article-title":"Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients.","volume":"64","author":"Kayaaslan","year":"2021","journal-title":"Mycoses"},{"key":"R18-20260410","first-page":"71","article-title":"Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.","volume":"44","author":"Chiurlo","year":"2021","journal-title":"New Microbiol"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cmi.2020.10.021","article-title":"Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.","volume":"27","author":"Ripa","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.54962\/ankemderg.1163275","article-title":"Secondary infections in patients with COVID-19 and review of the literature: a retrospective study conducted at a university hospital. article in Turkish: (Covid-19 hastalarinda sekonder enfeksiyonlar ve literat\u00fcr\u00fcn g\u00f6zden ge\u00e7irilmesi: \u00dcniversite hastanesinde yapilan retrospektif bir \u00e7ali\u015fma).","volume":"36","author":"Erdal","year":"2022","journal-title":"J ANKEM"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"101251","DOI":"10.1016\/j.mycmed.2022.101251","article-title":"Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.","volume":"32","author":"Benedetti","year":"2022","journal-title":"J Mycol Med"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance.","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:54Z","timestamp":1785766914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048245","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2025-09-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}